Waters Showcasing First-Of-Its-Kind High Definition Mass Spectrometry
System and Important Partnerships
CHICAGO, Feb. 26 /PRNewswire-FirstCall/ -- Continuing to build momentum
on the innovative successes of 2006, and to complement the launch of its
new branding campaign, The Science of What's Possible(TM), Waters
Corporation (NYSE: WAT) is showcasing a host of impressive new products and
sharing news of its exciting collaborations at the 58th Pittsburgh
Conference on Analytical Chemistry and Applied Spectroscopy, February 25 --
March 2.
Highlighting Waters product news is the Pittcon premiere of a first-of-
its-kind mass spectrometry system, the Synapt(TM) High Definition MS(TM)
(HDMS) System, and a benchtop, ultra-compact, tandem-quadrupole,
atmospheric pressure ionization mass detector called the Waters TQ Detector
used in conjunction with Waters(R) ACQUITY(TM) UPLC(R) System.
Making Waves in Mass Spectrometry
The Synapt HDMS(TM) system is the first mass spectrometer of its kind
to employ new ion mobility technology and software to enable the analysis
of sample ions differentiated by size, charge, shape and mass. This
additional dimension of separations fidelity leads to improved specificity
and sample definition, allowing scientists to extract more information
about their samples, including the detection of previously unseen
constituents.
A key feature of this new system is the patented Waters Triwave(TM)
technology, a unique method for combining highly efficient ion mobility
based measurement and separations with high performance quadrupole
time-of-flight mass spectrometry. Operational control and data acquisition
and processing are performed through Waters MassLynx(TM) Software.
Waters is also showcasing its new tandem UPLC/MS/MS system solution,
the ACQUITY TQD, allowing chromatographers to easily and confidently
acquire UPLC/MS/MS data in routine analytical and open access settings.
This UPLC/MS/MS system features the new Waters TQD -- a benchtop,
ultra-compact, tandem-quadrupole, atmospheric pressure ionization (API)
mass detector designed for routine UPLC/MS/MS analyses. With
first-of-its-kind IntelliStart(TM) technology to integrate the internal
calibration fluidics and advanced diagnostics software, the system
automatically tunes and calibrates the ACQUITY TQD System and conducts full
UPLC/MS/MS performance checks.
Making a Difference in People's Lives
Waters arrives at this year's Pittcon as a new, proud partner to a
number of the world's most dedicated healthcare companies, renowned
academic research facilities, and esteemed government agencies.
Dedicated Healthcare Companies
Waters and Advion Biosciences, Inc., of Ithaca, NY, also recently
integrated a number of their products to offer life scientists enhanced
research capabilities. The Advion(TM) TriVersa(TM) NanoMate chip-based
infusion technology was combined with Waters Synapt HDMS System to help
researchers maximize the amount of information they can extract from their
complex samples by combining the ease-of-use and reproducibility of
Advion's nanoelectrospray chip-based sample introduction technology with
the additional dimension of ion mobility-based separation provided by the
Synapt HDMS System. This technology is one of the most advanced of its
kind, and it supports the life-saving research of the world's top
pharmaceutical companies, government life science research agencies, and
universities.
Renowned Academic Research Facilities
At the start of 2007, two world-renowned research institutions, the Max
Planck Institute and Oxford University, added the Waters Synapt HDMS System
to their research technologies. Max Planck's Department of Cellular
Biochemistry is now employing the Synapt HDMS System to study the role of
proteins in causing brain-wasting diseases, including Huntington's.
Similarly, Oxford is using the Synapt HDMS System to study multi-component
protein complexes that can help answer questions like how to starve
cancerous tumors of oxygen and how to oxygenate and, some day, restore
heart tissue damaged by various forms of heart disease.
In late 2006, London's Imperial College unveiled a new state-of-the-art
NMR facility incorporating the mass spectrometry-based Waters Laboratory of
Molecular Spectroscopy. The collaboration and new facility allows
researchers at Waters and Imperial College to address fundamental
medicinal-biology problems, which are helping pave the way for a better
understanding of the underlying causes of disease and the effect of
lifestyle and diet on health. The work being done at this library is
helping to provide the tools necessary to make significant steps toward the
goal of personalized medicine.
Esteemed Government Organizations
This month, Waters entered into a Cooperative Research and Development
Agreement (CRADA) with the U.S. Environmental Protection Agency's (EPA)
National Exposure Research Laboratory to develop trace level analytical
methods for detecting levels of perfluorinated compounds (PFCs) in soil and
water. Waters and EPA scientists will develop analytical methods employing
liquid chromatography and mass spectrometry to measure PFCs at very low
concentrations in water and soil. CRADA will then focus on providing
answers as to the exposure risks of these pollutants to humans.
In the summer of 2006, Waters announced collaborations with the China
Municipal Center for Disease Prevention and Control (China CDC), Beijing
Municipal Center for Disease Prevention and Control (BJCDC) and The
Research Center for Eco-Environmental Sciences (RCEES) of the Chinese
Academy of Sciences to provide technology and expertise for food safety
analysis and environmental regulatory compliance. This joint collaboration
with China's premier food safety and environmental centers signifies a
strong vote of confidence in Waters and its commitment to address China's
rapidly increasing food safety and environmental challenges, particularly
as the country moves toward hosting the 2008 Olympics.
Our Pittcon Offerings
Waters Corporation is consolidating its instrumentation, chemistry, and
informatics products into Booth 3641.
News Conference
Waters' Pittcon 2007 News Conference, featuring Mary Ellen Goffredo,
Senior Director, Systems Product Marketing, Waters Corporation will be held
Monday, February 26th, from 8:30am-9:30am at McCormick Place South, Room
S105A.
Scientific Presentations
Waters will host a variety of oral/poster sessions and symposia that
will provide the ideal environment in which to share knowledge, expertise
and the latest application approaches to solving analytical challenges
using the most advanced mass spectrometry technology.
Morning and afternoon sessions will include a number of presentations
and 27 educational seminars by leading scientists on the topics of drug
discovery, metabolite identification, food safety, environmental health,
and protein characterization.
Presentation topics will include:
-- Simplifying the Purification Process
-- The Identification of New Novel BioMarkers of Disease and Toxicity
-- Applications of a New Amino Acid Analysis Method
-- Identification of Impurities Using Liquid Chromatography Hyphenated
with Tandem Mass Spectrometry
-- Screening of Drinking Water for Deleterious Organics Using LCMS and
Automatic Library Searching
-- The Rapid Analysis of Anthocyanidins in Berries
-- Determination of Priority Pesticide Residues in Baby Food
-- Solving Real Metabolism Problems by Using Small Particles, High
Temperatures and Long Columns to Produce an Ultra High Resolution
LC/MS System
Waters will also host a special Food Safety symposium on Thursday,
March 1, which will include a cross-section of representatives from
industry, government and food suppliers. The panel will discuss the use of
analytical technologies for solving food safety issues in an increasingly
complex and vigilant global marketplace.
For more information on Waters' conference offerings, please visit:
http://www.waters.com/pittcon
About Waters Corporation (http://www.waters.com)
Waters Corporation (NYSE: WAT) creates business advantage for
laboratory- dependent organizations by delivering practical and sustainable
innovation to enable significant advancements in such areas as healthcare
delivery, environmental management, food safety, and water quality
worldwide.
Pioneering a connected portfolio of separations science, laboratory
information management, mass spectrometry and thermal analysis, Waters
technology breakthroughs and laboratory solutions provide an enduring
platform for customer success.
With revenue of $1.28 billion in 2006 and 4,500 employees, Waters is
driving scientific discovery and operational excellence for customers
worldwide.
Waters, ACQUITY, UPLC, ACQUITY UPLC, Synapt, High Definition MS, HDMS,
Triwave, MassLynx, The Science of What's Possible and IntelliStart are
trademarks of Waters Corporation. Advion, NanoMate and TriVersa are
trademarks of Advion Biosciences, Inc.
Investor Contact: Media Contact:
Gene Cassis Brian J. Murphy
Vice President, Investor Relations Corporation Communications
508-482-2349 508-482-2614
Gene_Cassis@waters.com Brian_J_Murphy@waters.com
SOURCE Waters Corporation
 back to top
Related links:
http://www.waters.com/pittcon
http://www.waters.com
CONTACT:
Investors, Gene Cassis, Vice President,
Investor Relations, +1-508-482-2349, Gene_Cassis@waters.com, or
Media, Brian J. Murphy, Corporation Communications,
+1-508-482-2614, Brian_J_Murphy@waters.com, both of Waters
Corporation
|
